FDA puts on hold Blueprint Medicines’ clinical trial for solid cancers
The USFDA has put on hold Blueprint Medicines Corporation's clinical trial of BLU-222 due to visual adverse events seen in some patients, according.
Drugs
Pharma
Drugs
Medical
Pharma
Blood cancer therapy may help to treat ovarian cancer: Swedish scientists
A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s.
Drugs
Pharma
BioNTech to invest $43 million in new mRNA facility
BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.
Medical
Pharma
BioNTech signs MoU with UK govt to start clinical trials for mRNA cancer vaccine
BioNTech signs MoU with the British government to start mRNA cancer trials
Drugs
Pharma
Aurobindo Pharma gets FDA nod for injection to treat cancer
Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.
Drugs
Pharma
Israeli researchers develop artificially intelligent pathological assistants
Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.
Drugs
Health
Popular variant of Vitamin B3 may cause cancer, finds study
Some vitamins can have fatal side-effects as a new study finds that Niacin may carry risk of brain cancer
Drugs
Health
Medical
WHO says 3.5 billion people globally have oral diseases
About 45% of the world’s population, or 3.5 billion people, are suffering from oral diseases, a new study states.
Drugs
Pharma
EMA cracks the whip on JAK inhibitors for inflammatory disorders
The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.